There have been conflicting reports on the benefits of statins (HMG CoA reductase inhibitors) in patients with Alzheimer’s disease and the importance of cholesterol biosynthesis in the pathophysiology of AD.
It takes 30 seconds or login using your email address
Please enter the email address that you registered the newsletter with
